FDA Inspection
Intercept Pharmaceuticals, Inc.Intercept Pharmaceuticals, Inc. – FDA Inspection, Apr 22, 2024
Record Details
This FDA Inspection record concerns Intercept Pharmaceuticals, Inc., with an inspection on April 22, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 3a3ba5e7-11c8-4c49-8ecc-4b9fc08ccad1
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1236571
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 312.50General responsibilities of sponsors
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Intercept Pharmaceuticals, Inc.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| November 14, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Intercept Pharmaceuticals, Inc.
- FDA Inspection 1257609 - 2024-11-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.